Two Phase I and Pharmacokinetic Studies of Darinaparsin (Organic Arsenic Compound) in Japanese and Korean Patients with Relapsed or Refractory (R/R) Peripheral T-Cell Lymphoma (PTCL)

被引：0
|
作者：
Kim, Won-Seog [1 ]
Ogura, Michinori [2 ,3 ]
Uchida, Toshiki [3 ]
Uike, Naokuni [4 ,5 ]
Abe, Yasunobu [5 ]
Ishizawa, Kenichi [6 ,7 ]
Okitsu, Yoko [6 ]
Tobinai, Kensei [8 ]
Nagahama, Fumiko [9 ]
Sonehara, Yusuke [9 ]
Nagai, Hirokazu [10 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Hematol Oncol, Seoul, South Korea
[2] Tokai Cent Hosp, Dept Hematol, Kakamigahara, Japan
[3] Nagoya Daini Red Cross Hosp, Dept Hematol & Oncol, Nagoya, Aichi, Japan
[4] Saga Ken Med Ctr Koseikan, Dept Pallit Care, Saga, Japan
[5] Kyushu Canc Ctr, Natl Hosp Org, Dept Hematol, Fukuoka, Japan
[6] Tohoku Univ Hosp, Dept Hematol & Rheumatol, Sendai, Miyagi, Japan
[7] Yamagata Univ, Fac Med, Hematol & Cell Therapy, Yamagata 990, Japan
[8] Natl Canc Ctr, Tokyo, Japan
[9] Solasia Pharma KK, Dev Div, Tokyo, Japan
[10] Nagoya Med Ctr, Natl Hosp Org, Clin Res Ctr, Nagoya, Aichi, Japan
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Belinostat, a novel pan-histone deacetylase inhibitor (HDACi), in relapsed or refractory peripheral T-cell lymphoma (R/R PTCL): Results from the BELIEF trial
    O'Connor, Owen A.
    Masszi, Tamas
    Savage, Kerry J.
    Pinter-Brown, Lauren C.
    Foss, Francine M.
    Popplewell, Leslie
    Cashen, Amanda F.
    Doorduijn, Jeanette
    Chawla, Shanta
    Knoblauch, Poul
    Zinzani, Pier Luigi
    Brown, Peter
    Hess, Georg
    Van Hoof, Achiel
    Horwitz, Steven M.
    Shustov, Andrei R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [32] Phase II study of E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T-cell lymphoma
    Kawai, Hidetsugu
    Ando, Kiyoshi
    Maruyama, Dai
    Yamamoto, Kazuhito
    Kiyohara, Eiji
    Terui, Yasuhito
    Fukuhara, Noriko
    Miyagaki, Tomomitsu
    Tokura, Yoshiki
    Sakata-Yanagimoto, Mamiko
    Igarashi, Tadahiko
    Kuroda, Junya
    Fujita, Jiro
    Uchida, Toshiki
    Ishikawa, Takayuki
    Yonekura, Kentaro
    Kato, Koji
    Nakanishi, Tadashi
    Nakai, Kenya
    Matsunaga, Risa
    Tobinai, Kensei
    [J]. CANCER SCIENCE, 2021, 112 (06) : 2426 - 2435
  • [33] Pooled analysis of romidepsin in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL) following prior systemic therapy
    Bates, Susan
    Foss, Francine
    Piekarz, Richard
    Horwitz, Steven
    Pro, Barbara
    Prince, Miles
    Sokol, Lubomir
    Greenwood, Matthew
    Caballero, Dolores
    Borchmann, Peter
    Morschhauser, Franck
    Wilhelm, Martin
    Pinter-Brown, Lauren
    Padmanabhan, Swaminathan
    Shustov, Andrei
    Wright, John
    Kirschbaum, Mark
    Zain, Jasmine
    Allen, Steven L.
    Jaffe, Elaine S.
    Nichols, Jean
    Wolfson, Julie
    Balser, John
    Coiffier, Bertrand
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : 22 - 22
  • [34] Multicenter Phase I Dose-Escalation Study of Lenalidomide in Patients with Relapsed Adult T-Cell Leukemia-Lymphoma (ATL) or Peripheral T-Cell Lymphoma (PTCL)
    Uike, Naokuni
    Ogura, Michinora
    Imaizumi, Yoshitaka
    Asou, Norio
    Utsunomiya, Atae
    Uchida, Toshiki
    Aoki, Tomohiro
    Tsukasaki, Kunihiro
    Taguchi, Jun
    Choi, Ilseung
    Maruyama, Dai
    Nosaka, Kisato
    Chen, Nianhang
    Shiota, Tetsuhiro
    Tobinai, Kensei
    [J]. BLOOD, 2012, 120 (21)
  • [35] A Phase II Trial of Brentuximab Vedotin (BV) and Lenalidomide (Len) in Relapsed and Refractory (r/r) Cutaneous (CTCL) and Peripheral (PTCL) T-Cell Lymphomas; Preliminary Results
    William, Basem
    Huang, Ying
    Brammer, Jonathan
    Chung, Catherine
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S359 - S360
  • [36] A Meta-Analysis of Pivotal Pralatrexate Studies in Relapsed/Refractory Mature T-Cell Lymphoma (r/r TCL)
    O'Connor, Owen A.
    Ko, Bor-Sheng
    Wang, Ming-Chung
    Maruyama, Dai
    Song, Yuqin
    Yeoh, Ee-Min
    Tobinai, Kensei
    [J]. BLOOD, 2021, 138
  • [37] Analysis of Patients with Common Peripheral T-Cell Lymphoma Subtypes From a Phase 2 Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma
    Coiffier, Bertrand
    Pro, Barbara
    Prince, H. Miles
    Foss, Francine M.
    Sokol, Lubomir
    Greenwood, Matthew
    Caballero, Dolores
    Borchmann, Peter
    Morschhauser, Franck
    Wilhelm, Martin
    Pinter-Brown, Lauren
    Padmanabhan, Swaminathan
    Shustov, Andrei R.
    Nichols, Jean
    Carroll, Susan
    Balser, John
    Horwitz, Steven M.
    [J]. BLOOD, 2011, 118 (21) : 272 - 272
  • [38] Results of a Phase 2 NCI Multicenter Study of Romidepsin in Patients with Relapsed Peripheral T-Cell Lymphoma (PTCL)
    Piekarz, Richard
    Wright, John
    Frye, Robin
    Allen, Steven L.
    Craig, Michael
    Geskin, Larisa
    Hutchins, Laura
    Joske, David
    Kirschbaum, Mark
    Leonard, John P.
    Prince, Miles
    Reeder, Craig B.
    Jaffe, Elaine
    Bates, Susan
    [J]. BLOOD, 2008, 112 (11) : 555 - 556
  • [39] Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma
    Krishnan, Mridula
    Bociek, R. Gregory
    Fanale, Michelle
    Iyer, Swaminathan P.
    Lechowicz, Mary Jo
    Bierman, Philip J.
    Armitage, James O.
    Lunning, Matthew
    Kallam, Avyakta
    Vose, Julie M.
    [J]. ANNALS OF HEMATOLOGY, 2022, 101 (02) : 335 - 340
  • [40] Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma
    Mridula Krishnan
    R. Gregory Bociek
    Michelle Fanale
    Swaminathan P. Iyer
    Mary Jo Lechowicz
    Philip J. Bierman
    James O. Armitage
    Matthew Lunning
    Avyakta Kallam
    Julie M. Vose
    [J]. Annals of Hematology, 2022, 101 : 335 - 340
12345